Comments on Reporting Threshold for Institutional Investment Managers

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
A: 86
B: 3

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Ankur Modi
Public Comment Anonymous
Public Comment Brad Hight
Public Comment Cass Sanford, Associate General Counsel and Daniel Zinn, General Counsel, OTC Markets Group Inc.
Public Comment James J. Angel, Ph.D., CFP®, CFA, Associate Professor of Finance, McDonough School of Business, Georgetown University
Public Comment James K. Ciroli, Chief Financial Officer, Bryan L. Marx, Chief Accounting Officer, Kenneth Schellenberg, Vice President Investor Relations, Flagstar Bancorp, Inc.
Public Comment Jean-Luc Nouzille
Public Comment Kelly Reisdorf, Chief Investor Relations and Communications Office, Vista Outdoor, Inc.
Public Comment Lev Bagramian, Senior Securities Policy Advisor, Better Markets
Public Comment Nathan Wang
Public Comment Robert L. Reynolds, President and Chief Executive Officer, Putnam Investments
Public Comment Sean Miller
Public Comment Sumit Gupta
Public Comment Aaron Hoffman, Vice President, Investor Relations, TransUnion
Public Comment Aharon Levy
Public Comment Akin S. Harrison, SVP, General Counsel and Secretary, TEGNA Inc.
Public Comment Alexander Bierce
Public Comment Amanda Atlas
Public Comment Andy Grossman, EVP, Capital Markets & Investor Relations
Public Comment Antonsen Agathe Boulanger
Public Comment Bess Gallanis, BGI Communications
Public Comment Bob Allan
Public Comment Brian Hamburger, President and CEO, MarketCounsel Consulting, LLC
Public Comment Campbell Pryde, XBRL US
Public Comment Caron A. Lawhorn, Senior Vice President & Chief Financial Officer, One Gas
Public Comment Chris Iacovella
Public Comment Chris Netram, Vice President, Tax and Domestic Economic Policy, National Association of Manufacturers
Public Comment Christiano Gallo
Public Comment Christopher M. Kearns, CEO, BNY Mellon
Public Comment Christopher P. Molineaux, President & CEO, Life Sciences Pennsylvania

Last Reviewed or Updated: Dec. 18, 2025

File Number
S7-08-20
Release Number
34-89290
Related Materials
How to submit comments